Alessio Aghemo

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (24)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (19)

Giuseppe CHIRICO

full professor in applied physics

University of Milano-Bicocca

ITALY

View details

Stefano Fagiuoli

full professor of Gastroenterology

University of Milano-Bicocca

ITALY

View details

Fausto Catena

University of Bologna

ITALY

View details

Pietro Lampertico

University of Milan

ITALY

View details

Maria Rescigno

Humanitas University

ITALY

View details

Boxuan Yu

Nanyang Technological University (NTU)

SINGAPORE

View details

Alejandro Forner

SPAIN

View details

Utpal Pajvani

UNITED STATES

View details

Tommaso Lorenzo Parigi

University of Birmingham

UNITED KINGDOM

View details

Nicola Pugliese

Humanitas University

ITALY

View details

Ana LLEO

Professor of Internal Medicine

Humanitas University

ITALY

View details

EZIO LANZA

Humanitas University

ITALY

View details

Luca V. C. Valenti

ITALY

View details

Gaetano Gallo

ITALY

View details

Stefano Romeo

SWEDEN

View details

Alessandro Repici

Humanitas University

ITALY

View details

Massimo Puoti

Professore Straordinario

University of Milano-Bicocca

ITALY

View details

Ligen Yu

Nanyang Technological University (NTU)

SINGAPORE

View details

Mohammad Amjad Kamal

SAUDI ARABIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Alessio Aghemo

Research Interests

Explore related searches

Contact this professor

Articles (24)

Liver transplantation for HBV-related liver disease: Impact of prophylaxis for HBV on HCC recurrence

Anatomic sub-segmentectomy with single-session combined transcatheter arterial embolization/microwave ablation for the treatment of hepatocellular carcinoma: preliminary results

From Guidelines to Real‐Time Conversation: Expert‐Validated Retrieval‐Augmented and Fine‐Tuned GPT‐4 for Hepatitis C Management

Assessing the diagnostic accuracy of ChatGPT-4 in the histopathological evaluation of liver fibrosis in MASH

Drug–Drug Interactions Between DAAs and Anticoagulants or Antiplatelets: A Position Paper of the Italian Anticoagulation Clinics

Assessment of ChatGPT-generated medical Arabic responses for patients with metabolic dysfunction-associated steatotic liver disease

Burden of cancer attributable to high body mass index: A systematic analysis of the Global Burden of Disease Study 2021

Characterizing porto-sinusoidal vascular disorder in patients without signs of portal hypertension

Incidence and Predictors of Complications Following Percutaneous Liver Biopsy: A Large Italian Multicentre Study

Is ChatGPT-4 a Reliable Tool in Autoimmune Hepatitis?

The first <scp>MASH</scp> drug therapy on the horizon: Current perspectives of resmetirom

Prevalence of HCV infection in Europe in the DAA era: Review

Clinical features and management issues of NAFLD-related HCC: what we know so far

SARS-CoV-2 Infection, Inflammation, Immunonutrition, and Pathogenesis of COVID-19

Should Artificial Intelligence‐based language models be allowed in developing scientific manuscripts? A debate between ChatGPT and the editors of Liver International

Accuracy, reliability and comprehensiveness of ChatGPT generated medical responses for patients with NAFLD

Safety and effectiveness of 8 weeks of Glecaprevir/Pibrentasvir in challenging HCV patients: Italian data from the CREST study

Forecasting the long‐term impact of COVID‐19 on hepatitis C elimination plans in Italy: A mathematical modelling approach

Measuring the impact of the updated Steatotic liver disease nomenclature and definition

Liver biopsy is associated with increased body weight loss in patients with non‐alcoholic steatohepatitis

High prevalence of porto‐sinusoidal vascular disease in patients with constantly elevated gamma‐glutamyl transferase levels

No impact of COVID‐19 epidemic on decompensation of alcoholic liver disease: Results from a single‐centre in Milan

No impact of COVID‐19 epidemic on decompensation of alcoholic liver disease: Results from a single centre in Milan

Is there an ‘ideal’ diet for patients with NAFLD?

Collaborators (19)

Giuseppe CHIRICO

Stefano Fagiuoli

Fausto Catena

Pietro Lampertico

Maria Rescigno

Boxuan Yu

Alejandro Forner

Utpal Pajvani

Tommaso Lorenzo Parigi

Nicola Pugliese

Ana LLEO

EZIO LANZA

Luca V. C. Valenti

Gaetano Gallo

Stefano Romeo

Alessandro Repici

Massimo Puoti

Ligen Yu

Mohammad Amjad Kamal

Make your next move.